Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pathology|April 27, 2010
HER-2/NEU overexpression in vulvar Paget disease: the Yale experienceChristine E Richter, Pei Hui, Natalia Buza, et al.
Gynecologic Oncology|March 21, 2015
Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective reviewDana M Roque, Elena S Ratner, Dan-Arin Silasi, et al.
The Yale Journal of Biology and Medicine|October 18, 2007
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancerDan-Arin Silasi, Ayesha B Alvero, Jessica Illuzzi, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|August 25, 2020
Laparoscopic Posterior Versus Lateral Transversus Abdominis Plane Block in GynecologyKelly Benabou, Soorin Kim, Christina H Tierney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 14, 2014
Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted stagingGulden Menderes, Masoud Azodi, Lindsay Clark, et al.
Gynecologic and Obstetric Investigation|June 13, 2015
Management of Borderline Ovarian Tumors Based on Patient and Tumor CharacteristicsJonathan D Black, Gary H Altwerger, Elena Ratner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapyStefania Bellone, Eric R Siegel, Emiliano Cocco, et al.
Gynecologic Oncology|October 5, 2011
The significance of perineural invasion in early-stage cervical cancerKarim S Elsahwi, Emma Barber, Jessica Illuzzi, et al.
American Journal of Obstetrics and Gynecology|September 28, 2010
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibodyChristine E Richter, Emiliano Cocco, Stefania Bellone, et al.
Journal of Contemporary Brachytherapy|April 2, 2015
High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinomaShari Damast, Susan A Higgins, Elena Ratner, et al.
Pageof 15